Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the FDA’s dietary supplement manufacturing regulations and other requirements listed in a ...
read more
Wednesday, January 04, 2017
Custopharm, Inc. has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company.
read more
Tuesday, November 15, 2016
CutisPharma has announced the opening of a Research and Development center to house the company's expanding R&D team. The new center will provide office and laboratory space to facilitate the company's aggressive plans for developing products for FDA...
read more
Wednesday, August 05, 2015
Pricey specialty drugs helped CVS Health cope with tobacco withdrawal and top analyst expectations in the second quarter.
read more
CVS Health today announced its new Clinical Trial Services business that brings together innovation and experience to drive greater access to clinical trials across the communities it serves and create a more efficient, convenient experience to ...
read more
Wednesday, March 30, 2022
CVS Health has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for opioid medications that were filled at Florida CVS Pharmacy locations.
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more
Thursday, October 31, 2019
Cycle has signed an agreement with Catalent to develop innovative formulations targeting rare disease patients.
read more
Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a ...
read more
Wednesday, October 30, 2019
Cyclo Therapeutics has signed an agreement with Worldwide Clinical Trials, a CRO, to conduct a clinical trial to evaluate safety and efficacy in Alzheimer’s Disease.
read more
Monday, December 30, 2019
Cyclo Therapeutics has signed a Master Services Agreement with Worldwide Clinical Trials to serve as CRO for the Company’s clinical programs evaluating Trappsol Cyclo.
read more
Thursday, January 14, 2021
Cyclolab and EpiPharma have signed an agreement to form a joint venture specialty pharmaceutical company to develop and commercialize novel conjugated Cyclodextrin.
read more
Cyrus Biotechnology announced the release of a novel Antibody Structure Prediction Software tool as part of its Cyrus Bench® platform.
read more
Sunday, September 18, 2016
The Cystic Fibrosis Foundation has announced the official opening of a new, one-of-a kind research facility in Lexington, Mass. Operated by Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), an affiliate of the CF Foundation, the lab is designed to...
read more
Monday, September 07, 2020
Cytel has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation.
read more